, which ranks the world’s biggest public companies. It was a mixed bag in terms of overall rankings in the sector with some companies slipping from last year, while others rose, but only one healthcare company that ranked in the top 100 last year didn’t make the cut. That was GlaxoSmithKline, which fell 32 spots to No. 129 as the U.K.
UnitedHealth Group was the highest-ranked healthcare company at No. 22 overall – one spot lower than last year’s ranking. Over the 12 months to April 2022, when the Global 2000 list was finalized, the Minnetonka, Minnesota-based company generated $297.6 billion in revenue, $17.5 billion in profits and a market capitalization of $490.2 billion.
The highest-ranked pharmaceutical company was Johnson & Johnson, which came in at No. 39 overall. It was a slight dip from last year, when J&J ranked five spots higher. The New Brunswick, New Jersey-based company posted $94.9 billion in revenue, $19.8 billion in profits and a market capitalization of $477.4 billion as of April 20.